SRPK2 and melanoma: This study aims to determine the clinical relevance of SRPK1 and SRPK2 expression regarding dataset analysis before examining the effects of SRPK inhibitors, SRPIN340 and SPHINX31, on cell viability and growth in the melanoma cell lines, A375 and MNT-1.